ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      Centre releases 50 pc funds of COVID-19 Emergency Response...

Centre releases 50 pc funds of COVID-19 Emergency Response...

New Delhi [India], August 13 (ANI): In order to strengthen the fight of the States and Union Territories against the...

      
      Migsun achieves CC 450 days before RERA Timeline for Migsun...

Migsun achieves CC 450 days before RERA Timeline for Migsun...

Greater Noida (Uttar Pradesh) [India], July 30 (ANI/NewsVoir): Migsun Group, one of the leading real estate...

      
      Optimus announces Interim Clinical Results from Phase III...

Optimus announces Interim Clinical Results from Phase III...

Hyderabad (Telangana) [India], July 21 (ANI/PNN): Optimus Pharma on Sunday submitted the interim result of Phase III...

      
      Health Ministry asks states, UTs to review infrastructure...

Health Ministry asks states, UTs to review infrastructure...

New Delhi [India], July 15 (ANI): Union Health Ministry on Thursday asked states and Union Territories (UTs) to...

      
      Hetero announces interim clinical results from Phase III...

Hetero announces interim clinical results from Phase III...

Hyderabad (Telangana) [India], July 9 (ANI): Hetero, a globally renowned vertically integrated pharmaceutical...

      
      Cabinet approves Rs 23,123 cr India COVID-19 Emergency...

Cabinet approves Rs 23,123 cr India COVID-19 Emergency...

New Delhi [India], July 8 (ANI): The Union Cabinet chaired by Prime Minister Narendra Modi has approved a new scheme...

      
      Glenmark to conduct phase III trials of nasal spray it claims...

Glenmark to conduct phase III trials of nasal spray it claims...

New Delhi [India], July 8 (ANI): Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray,...

      
      DCGI likely to approve phase 3 trial data of Covaxin on Tuesday

DCGI likely to approve phase 3 trial data of Covaxin on Tuesday

New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III...


      
      Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III...

Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III...

New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert...

      
      DCGI's expert panel to review Phase III data of Covaxin today

DCGI's expert panel to review Phase III data of Covaxin today

New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss...


      
      Bharat Biotech has submitted Covaxin's Phase III trial data...

Bharat Biotech has submitted Covaxin's Phase III trial data...

New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech...


      
      IREDA extends bid submission to June 15 for implementation of...

IREDA extends bid submission to June 15 for implementation of...

New Delhi [India], June 7 (ANI): Indian Renewable Energy Development Agency Limited (IREDA), a PSU under the...
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.